Collegium Pharmaceutical: Q4 Earnings Snapshot

STOUGHTON, Mass. (AP) — STOUGHTON, Mass. (AP) — Collegium Pharmaceutical Inc. (COLL) on Thursday reported a loss of $7.2 million in its fourth quarter.

On a per-share basis, the Stoughton, Massachusetts-based company said it had a loss of 21 cents. Earnings, adjusted for one-time gains and costs, came to $1.09 per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of $1.03 per share.

The specialty pharmaceutical company posted revenue of $129.6 million in the period, also surpassing Street forecasts. Three analysts surveyed by Zacks expected $127.1 million.

For the year, the company reported a loss of $25 million, or 74 cents per share, swinging to a loss in the period. Revenue was reported as $463.9 million.

Collegium Pharmaceutical expects full-year revenue in the range of $565 million to $580 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on COLL at

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up